Skip to main content
Robert Dean, MD, Oncology, Cleveland, OH, Cleveland Clinic

RobertMDeanMD

Oncology • Cleveland, OH

Hematologic Oncology

Staff, Cleveland Clinic Taussig Cancer Institute | Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Join to view full profile

Dr. Dean is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dean's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2000 - 2005
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2000
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1996 - 1999
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1996

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2005 - 2025
  • MA State Medical License
    MA State Medical License 1998 - 2005
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Publications & Presentations

PubMed

Journal Articles

  • Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
    Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
  • Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days  
    Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

  • Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cleveland Clinic Cancer Doctor
    Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships

Hospital Affiliations

Dr. Robert Dean, Dr. Robert Dean, MD, Dr. R Dean, Dr. Robert M Dean